We found that the expression level of RPL31 mRNA was significantly elevated in BicR cells compared with LNCaP cells, and clinical studies show that RPL31 expression in prostate carcinoma is higher than that in benign prostate tissues. This evidence concerns the gene RPL31 and prostate carcinoma.